12 Transforming the Drug Development Landscape
Also Heading to the Clinic
Novel Stem Cell Trial Begins
A trial implanting dopamine cells created from engineered stem cells began in June . MJFF funded original studies to create dopamine cells — which are lost in Parkinson ’ s — from this type of stem cell .
Troublesome Symptoms the Focus of New Trials
In 2021 MJFF allocated nearly $ 11 million in grants funding new approaches to ease some of the most troubling symptoms of Parkinson ’ s , including constipation , depression , dyskinesia , gait freezing , speech issues , sleep problems and tremor .
$ 11M
to symptomatic therapies